GSA Capital Partners’s LIBERATOR MED HLDGS INC (NY) LBMH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-133,271
Closed -$445K 2119
2015
Q4
$445K Sell
133,271
-110,802
-45% -$322K 0.02% 1236
2015
Q3
$574K Buy
244,073
+24,400
+11% +$58.6K 0.03% 1047
2015
Q2
$499K Buy
219,673
+134,869
+159% +$391K 0.02% 1357
2015
Q1
$297K Buy
84,804
+17,647
+26% +$60.2K 0.01% 1715
2014
Q4
$195K Sell
67,157
-48,375
-42% -$136K 0.01% 1481
2014
Q3
$362K Sell
115,532
-194,005
-63% -$613K 0.02% 1136
2014
Q2
$1.16M Buy
309,537
+260,837
+536% +$1.01M 0.05% 580
2014
Q1
$191K Buy
+48,700
New +$214K 0.01% 1397

GSA Capital Partners's LBMH Position: Q1 2016 in Review

GSA Capital Partners sold out of LIBERATOR MED HLDGS INC (NY) (LBMH) in Q1 2016, closing a stake of 133,271 shares — an estimated $445K sold.

GSA Capital Partners first reported a position in LBMH in Q1 2014 and held it in 8 quarters. The position peaked at $1.16M in Q2 2014. 0 funds tracked by Wall St. Rank hold LBMH as of Q1 2016.

  • GSA Capital Partners reported no remaining LIBERATOR MED HLDGS INC (NY) position as of Q1 2016 after selling out during the quarter.
  • GSA Capital Partners sold 133,271 LIBERATOR MED HLDGS INC (NY) shares in Q1 2016, an estimated $445K.
  • GSA Capital Partners first reported a position in LIBERATOR MED HLDGS INC (NY) in Q1 2014 and held it in 8 quarters.
  • GSA Capital Partners's LIBERATOR MED HLDGS INC (NY) position peaked at $1.16M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held LIBERATOR MED HLDGS INC (NY) as of Q1 2016.

Based on GSA Capital Partners's 13F filing for Q1 2016, filed 11 May 2016.